Taysha Gene Therapies Ownership | Who Owns Taysha Gene Therapies?
Taysha Gene Therapies Ownership Summary
Taysha Gene Therapies is owned by 62.38% institutional investors, 18.34% insiders, and 19.28% retail investors. Avoro capital advisors is the largest institutional shareholder, holding 7.47% of TSHA shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.16% of its assets in Taysha Gene Therapies shares.
TSHA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Taysha Gene Therapies | 62.38% | 18.34% | 19.28% |
Sector | Healthcare Stocks | 56.95% | 9.26% | 33.79% |
Industry | Biotech Stocks | 68.60% | 8.88% | 22.52% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Avoro capital advisors | 20.00M | 7.47% | $34.60M |
Fmr | 16.37M | 6.11% | $28.31M |
Blackrock | 11.74M | 5.08% | $26.30M |
Blackrock funding, inc. /de | 13.53M | 5.05% | $23.41M |
Ra capital management | 10.87M | 4.06% | $18.81M |
Octagon capital advisors lp | 10.45M | 3.90% | $18.08M |
Vanguard group | 8.91M | 3.33% | $15.41M |
Rtw investments, lp | 8.67M | 3.24% | $15.00M |
Morgan stanley | 7.48M | 3.23% | $16.75M |
Siren | 6.60M | 2.47% | $11.42M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Octagon capital advisors lp | 10.45M | 2.97% | $18.08M |
Tybourne capital management (hk) | 3.70M | 1.61% | $6.40M |
Acuta capital partners | 884.24K | 1.54% | $1.53M |
Ghost tree capital | 1.25M | 0.88% | $2.80M |
Siren | 6.60M | 0.50% | $11.42M |
Avoro capital advisors | 20.00M | 0.49% | $34.60M |
Quantum private wealth | 794.98K | 0.44% | $1.38M |
Vr adviser | 3.23M | 0.38% | $5.58M |
Sands capital ventures | 724.87K | 0.27% | $1.25M |
Ra capital management | 10.87M | 0.25% | $18.81M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 11.74M | 0.00% | 9.15M |
Octagon capital advisors lp | 10.45M | 2.97% | 5.88M |
Adage capital partners gp | 5.00M | 0.02% | 5.00M |
State street | 6.47M | 0.00% | 3.01M |
Morgan stanley | 7.48M | 0.00% | 2.31M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Rtw investments, lp | 8.67M | 0.23% | -6.27M |
Vr adviser | 3.23M | 0.38% | -5.77M |
Deutsche bank ag\ | 151.08K | 0.00% | -2.41M |
Eversept partners, lp | - | - | -2.33M |
Fmr | 16.37M | 0.00% | -2.31M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Adage capital partners gp | 5.00M | 0.02% | 5.00M | $8.65M |
Norges bank | 1.46M | 0.00% | 1.46M | $2.53M |
Dafna capital management | 522.50K | 0.23% | 522.50K | $903.92K |
Rafferty asset management | 252.26K | 0.00% | 252.26K | $436.40K |
Aquatic capital management | 78.25K | 0.00% | 78.25K | $135.37K |
Sold Out
Holder | Change |
---|---|
Riggs asset managment | -198.00 |
Clear street markets | -424.00 |
Cwm | -499.00 |
Global retirement partners | -1.01K |
State of wyoming | -1.80K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 126 | 5.00% | 167,074,710 | 6.47% | 62 | 1.82% | 72 | -4.00% | 25 | 56.25% |
Sep 30, 2024 | 120 | 12.15% | 156,916,875 | -0.74% | 58 | 1.25% | 75 | 15.38% | 16 | -11.11% |
Jun 30, 2024 | 107 | -3.60% | 158,086,768 | 12.80% | 68 | 1.86% | 65 | -1.52% | 18 | -28.00% |
Mar 31, 2024 | 111 | 24.72% | 140,142,393 | 7.72% | 60 | 0.48% | 66 | 13.79% | 25 | 108.33% |
Dec 31, 2023 | 89 | 39.06% | 130,103,267 | 0.12% | 112 | 1.05% | 58 | 23.40% | 12 | 100.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl O | 6.48M | 3.16% | - |
Fidelity Growth Compy Commingled Pl S | 5.34M | 2.60% | 61.80K |
Vanguard Total Stock Mkt Idx Inv | 4.85M | 2.37% | - |
iShares Russell 2000 ETF | 4.75M | 2.32% | -36.10K |
Fidelity Growth Company Fund | 4.23M | 2.06% | -86.43K |
Fidelity Select Biotechnology | 4.20M | 2.05% | -1.37M |
Polar Capital Biotech S Inc | 3.00M | 1.46% | - |
SPDR® S&P Biotech ETF | 2.72M | 1.33% | -26.47K |
Xtrackers MSCI World Swap ETF 1C | 2.47M | 1.20% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 2.24M | 1.09% | 51.45K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jun 27, 2024 | Manning Paul B | - | Buy | $3.00M |
Nov 17, 2023 | Manning Paul B | - | Buy | $163.00K |
Aug 24, 2023 | Alam Kamran | Chief Financial Officer | Sell | $76.89K |
Aug 16, 2023 | Manning Paul B | - | Buy | $14.82M |
Aug 16, 2023 | Stalfort John A III | - | Buy | $350.00K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q2 | 1 | - |
2024 Q1 | - | - |
2023 Q4 | 1 | - |
2023 Q3 | 5 | 3 |
TSHA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools